메뉴 건너뛰기




Volumn 26, Issue 17, 2007, Pages 2445-2458

Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition

Author keywords

Apoptosis; Caspases; CML; Erythroid differentiation; Imatinib; PD166326

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 (2,6 DICHLOROPHENYL) 2 [3 (HYDROXYMETHYL)ANILINO] 8 METHYLPYRIDO[2,3 D]PYRIMIDIN 7(8H) ONE; ACTIVIN A; BCR ABL PROTEIN; CASPASE 3; IMATINIB; SMALL INTERFERING RNA;

EID: 34247145115     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210034     Document Type: Article
Times cited : (45)

References (32)
  • 1
    • 2642651899 scopus 로고    scopus 로고
    • Differential expression of the Kell blood group and CD10 antigens: Two related membrane metallopeptidases duringdifferentiation of K562 cells by phorbol ester and hemin
    • Belhacene N, Maulon L, Guerin S, Ricci JE, Mari B, Colin Y et al. (1998). Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases duringdifferentiation of K562 cells by phorbol ester and hemin. FASEB J 12: 531-539.
    • (1998) FASEB J , vol.12 , pp. 531-539
    • Belhacene, N.1    Maulon, L.2    Guerin, S.3    Ricci, J.E.4    Mari, B.5    Colin, Y.6
  • 2
    • 0033816156 scopus 로고    scopus 로고
    • Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
    • Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. (2000). Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295: 139-145.
    • (2000) J Pharmacol Exp Ther , vol.295 , pp. 139-145
    • Buchdunger, E.1    Cioffi, C.L.2    Law, N.3    Stover, D.4    Ohno-Jones, S.5    Druker, B.J.6
  • 3
    • 2542475112 scopus 로고    scopus 로고
    • Caspase-3 has a nonapoptotic function in erythroid maturation
    • Carlile GW, Smith DH, Wiedmann M. (2004). Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 103: 4310-4316.
    • (2004) Blood , vol.103 , pp. 4310-4316
    • Carlile, G.W.1    Smith, D.H.2    Wiedmann, M.3
  • 4
    • 0034670036 scopus 로고    scopus 로고
    • The molecular biology of chronic myeloid leukemia
    • Deininger MW, Goldman JM, Melo JV. (2000). The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356.
    • (2000) Blood , vol.96 , pp. 3343-3356
    • Deininger, M.W.1    Goldman, J.M.2    Melo, J.V.3
  • 5
    • 0037082489 scopus 로고    scopus 로고
    • Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2
    • Dorsey JF, Cunnick JM, Mane SM, Wu J. (2002). Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2. Blood 99: 1388-1397.
    • (2002) Blood , vol.99 , pp. 1388-1397
    • Dorsey, J.F.1    Cunnick, J.M.2    Mane, S.M.3    Wu, J.4
  • 6
    • 0034254249 scopus 로고    scopus 로고
    • Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
    • Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. (2000). Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96: 925-932.
    • (2000) Blood , vol.96 , pp. 925-932
    • Heinrich, M.C.1    Griffith, D.J.2    Druker, B.J.3    Wait, C.L.4    Ott, K.A.5    Zigler, A.J.6
  • 7
    • 7644231187 scopus 로고    scopus 로고
    • Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
    • Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F et al. (2004). Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23: 7863-7873.
    • (2004) Oncogene , vol.23 , pp. 7863-7873
    • Herrant, M.1    Jacquel, A.2    Marchetti, S.3    Belhacene, N.4    Colosetti, P.5    Luciano, F.6
  • 8
    • 0012907461 scopus 로고    scopus 로고
    • A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants
    • Huron DR, Gorre ME, Kraker AJ, Sawyers CL, Rosen N, Moasser MM. (2003). A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. Clin Cancer Res 9: 1267-1273.
    • (2003) Clin Cancer Res , vol.9 , pp. 1267-1273
    • Huron, D.R.1    Gorre, M.E.2    Kraker, A.J.3    Sawyers, C.L.4    Rosen, N.5    Moasser, M.M.6
  • 9
    • 32244434821 scopus 로고    scopus 로고
    • A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis
    • Jacquel A, Herrant M, Defamie V, Belhacene N, Colosetti P, Marchetti S et al. (2006). A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 25: 781-794.
    • (2006) Oncogene , vol.25 , pp. 781-794
    • Jacquel, A.1    Herrant, M.2    Defamie, V.3    Belhacene, N.4    Colosetti, P.5    Marchetti, S.6
  • 10
    • 0642303647 scopus 로고    scopus 로고
    • Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage
    • Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G et al. (2003). Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. FASEB J 17: 2160-2162.
    • (2003) FASEB J , vol.17 , pp. 2160-2162
    • Jacquel, A.1    Herrant, M.2    Legros, L.3    Belhacene, N.4    Luciano, F.5    Pages, G.6
  • 11
    • 1442355343 scopus 로고    scopus 로고
    • Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it
    • Kawano T, Horiguchi-Yamada J, Iwase S, Furukawa Y, Kano Y, Yamada H. (2004). Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it. Mol Cell Biochem 258: 25-33.
    • (2004) Mol Cell Biochem , vol.258 , pp. 25-33
    • Kawano, T.1    Horiguchi-Yamada, J.2    Iwase, S.3    Furukawa, Y.4    Kano, Y.5    Yamada, H.6
  • 12
    • 1242317094 scopus 로고    scopus 로고
    • Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells
    • Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M. (2004). Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J Cell Physiol 198: 370-376.
    • (2004) J Cell Physiol , vol.198 , pp. 370-376
    • Kohmura, K.1    Miyakawa, Y.2    Kawai, Y.3    Ikeda, Y.4    Kizaki, M.5
  • 13
    • 0037131970 scopus 로고    scopus 로고
    • Raf-1 antagonizes erythroid differentiation by restrainingcaspase activation
    • Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H et al. (2002). Raf-1 antagonizes erythroid differentiation by restrainingcaspase activation. J Exp Med 196: 1347-1353.
    • (2002) J Exp Med , vol.196 , pp. 1347-1353
    • Kolbus, A.1    Pilat, S.2    Husak, Z.3    Deiner, E.M.4    Stengl, G.5    Beug, H.6
  • 14
    • 24744456935 scopus 로고    scopus 로고
    • Nuclear substructure reorganization duringlate-stag e erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins
    • Krauss SW, Lo AJ, Short SA, Koury MJ, Mohandas N, Chasis JA. (2005). Nuclear substructure reorganization duringlate-stag e erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins. Blood 106: 2200-2205.
    • (2005) Blood , vol.106 , pp. 2200-2205
    • Krauss, S.W.1    Lo, A.J.2    Short, S.A.3    Koury, M.J.4    Mohandas, N.5    Chasis, J.A.6
  • 15
    • 25144471855 scopus 로고    scopus 로고
    • Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells
    • Kuzelova K, Grebenova D, Marinov I, Hrkal Z. (2005). Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells. J Cell Biochem 95: 268-280.
    • (2005) J Cell Biochem , vol.95 , pp. 268-280
    • Kuzelova, K.1    Grebenova, D.2    Marinov, I.3    Hrkal, Z.4
  • 17
    • 10744233716 scopus 로고    scopus 로고
    • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
    • O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. (2003). Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348: 994-1004.
    • (2003) N Engl J Med , vol.348 , pp. 994-1004
    • O'Brien, S.G.1    Guilhot, F.2    Larson, R.A.3    Gathmann, I.4    Baccarani, M.5    Cervantes, F.6
  • 18
    • 1542283719 scopus 로고    scopus 로고
    • A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: Caspase-independent, necrosis-like programmed cell death mediated by serine protease activity
    • Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M et al. (2004). A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 103: 2299-2307.
    • (2004) Blood , vol.103 , pp. 2299-2307
    • Okada, M.1    Adachi, S.2    Imai, T.3    Watanabe, K.4    Toyokuni, S.Y.5    Ueno, M.6
  • 19
    • 2942558439 scopus 로고    scopus 로고
    • Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells
    • Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L et al. (2004). Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem 279: 25345-25352.
    • (2004) J Biol Chem , vol.279 , pp. 25345-25352
    • Parmar, S.1    Katsoulidis, E.2    Verma, A.3    Li, Y.4    Sassano, A.5    Lal, L.6
  • 20
    • 0037383849 scopus 로고    scopus 로고
    • Caspase activation is not death
    • Perfettini JL, Kroemer G. (2003). Caspase activation is not death. Nat Immunol 4: 308-310.
    • (2003) Nat Immunol , vol.4 , pp. 308-310
    • Perfettini, J.L.1    Kroemer, G.2
  • 21
    • 0037330623 scopus 로고    scopus 로고
    • The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells
    • Pettiford SM, Herbst R. (2003). The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells. Leukemia 17: 366-378.
    • (2003) Leukemia , vol.17 , pp. 366-378
    • Pettiford, S.M.1    Herbst, R.2
  • 22
    • 0035808173 scopus 로고    scopus 로고
    • A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment
    • Racke FK, Wang D, Zaidi Z, Kelley J, Visvader J, Soh JW et al. (2001). A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment. J Biol Chem 276: 522-528.
    • (2001) J Biol Chem , vol.276 , pp. 522-528
    • Racke, F.K.1    Wang, D.2    Zaidi, Z.3    Kelley, J.4    Visvader, J.5    Soh, J.W.6
  • 23
    • 33644974753 scopus 로고    scopus 로고
    • Transient or long-term silencingof BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation
    • Rangatia J, Bonnet D. (2005). Transient or long-term silencingof BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 20: 68-76.
    • (2005) Leukemia , vol.20 , pp. 68-76
    • Rangatia, J.1    Bonnet, D.2
  • 24
    • 0141788346 scopus 로고    scopus 로고
    • STI-571: An anticancer protein-tyrosine kinase inhibitor
    • Roskoski Jr R. (2003). STI-571: an anticancer protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 309: 709-717.
    • (2003) Biochem Biophys Res Commun , vol.309 , pp. 709-717
    • Roskoski Jr, R.1
  • 25
    • 0037441756 scopus 로고    scopus 로고
    • Specific inhibition of bcr-abl gene expression by small interfering RNA
    • Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. (2003). Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101: 1566-1569.
    • (2003) Blood , vol.101 , pp. 1566-1569
    • Scherr, M.1    Battmer, K.2    Winkler, T.3    Heidenreich, O.4    Ganser, A.5    Eder, M.6
  • 27
    • 10744219596 scopus 로고    scopus 로고
    • Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
    • van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al. (2003). Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615.
    • (2003) EMBO Rep , vol.4 , pp. 609-615
    • van de Wetering, M.1    Oving, I.2    Muncan, V.3    Pon Fong, M.T.4    Brantjes, H.5    van Leenen, D.6
  • 28
    • 33644853211 scopus 로고    scopus 로고
    • RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killingby 17-allylamino-17- demethoxygeldanamycin
    • Withey JM, Harvey AJ, Crompton MR. (2005). RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killingby 17-allylamino-17- demethoxygeldanamycin. Leuk Res 30: 553-560.
    • (2005) Leuk Res , vol.30 , pp. 553-560
    • Withey, J.M.1    Harvey, A.J.2    Crompton, M.R.3
  • 29
    • 0141790842 scopus 로고    scopus 로고
    • Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)
    • Wohlbold L, Van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J et al. (2003). Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102: 2236-2239.
    • (2003) Blood , vol.102 , pp. 2236-2239
    • Wohlbold, L.1    Van der Kuip, H.2    Miething, C.3    Vornlocher, H.P.4    Knabbe, C.5    Duyster, J.6
  • 30
    • 18544366598 scopus 로고    scopus 로고
    • PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
    • Wolff NC, Veach DR, Tong WP, Bornmann WG, Clarkson B, Ilaria Jr RL. (2005). PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood 105: 3995-4003.
    • (2005) Blood , vol.105 , pp. 3995-4003
    • Wolff, N.C.1    Veach, D.R.2    Tong, W.P.3    Bornmann, W.G.4    Clarkson, B.5    Ilaria Jr, R.L.6
  • 31
    • 2542441665 scopus 로고    scopus 로고
    • The BCR-ABL story: Bench to bedside and back
    • Wong S, Witte ON. (2004). The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 22: 247-306.
    • (2004) Annu Rev Immunol , vol.22 , pp. 247-306
    • Wong, S.1    Witte, O.N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.